Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma.
Sponsor: University of Miami
Suspended
lack of funding
This observational or N/A phase trial investigates Calcium Oxalate Urolithiasis and Renal Cell Carcinoma and is currently suspended. University of Miami leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Oct 2025 — Present [monthly]
Suspended
Status: Recruiting → Suspended
-
Oct 2024 — Oct 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Apr 2023 — Oct 2023 [monthly]
Recruiting
-
May 2022 — Apr 2023 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Miami
For direct contact, visit the study record on ClinicalTrials.gov .